News
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
The US has approved lenacapavir for HIV prevention. But experts worry that cuts to the health budget will 'squander' the drug ...
16d
India Today on MSNLenacapavir becomes first FDA-approved HIV preventive drug: All about itThe US FDA has approved lenacapvir, sold under the brand name Yeztugo, as the first preventive treatment against HIV. It is a twice-yearly injectable drug developed for adults and teenagers.
7d
2UrbanGirls on MSNFunding restored for HIV prevention programs throughout LA CountyCongressional leaders celebrated the restored $20 million in previously frozen HIV prevention funds and surveillance programs ...
In the heart of Chicago’s Lakeview neighborhood, the work to shore up healthcare carries on at Howard Brown Health. “We are a ...
No, Atlanta is not experiencing an outbreak of HIV, although the rates of new diagnosis are considered high in some ...
Black people account for nearly 40% of those living with HIV in the U.S., according to the CDC. In the South, stigma and limits to health care access put people more at risk.
President Donald Trump's budget proposal for fiscal year 2026 requests significant reductions to HIV prevention and ...
Black people account for nearly 40% of those living with HIV in the U.S., according to the CDC. In the South, stigma and limits to health care access put people more at risk.
Hosted on MSN16d
FDA approves new twice-yearly HIV shot. What to knowMore than 4,700 deaths in 2023 were attributed to HIV, the virus that weakens the immune system and causes AIDS, the CDC said. A June stu d y estimated as many as 2.2 million Americans could ...
Black people account for nearly 40% of those living with HIV in the U.S., according to the CDC. In the South, stigma and limits to health care access put people more at risk.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results